Nicholas Ah Mew, M.D.,C.M., is Director of the Inherited Metabolic Disorders Program at Children’s National Health System and is Associate Professor of Pediatrics at The George Washington University. His research interests include disorders of ammonia metabolism and the urea cycle. He is the primary investigator of a federally-funded PCORI project whose aims are to compare the outcomes of patients with urea cycle disorders who have either received a liver transplant or received medical management. He is also co-chair of the N-Carbamylglutamate Consortium, which is evaluating carbamylglutamate as a treatment for acute hyperammonemia in the organic acidemias and urea cycle disorders. Additionally, Dr. Ah Mew is the Children’s National site Principal Investigator and an active member of the NIH-funded Urea Cycle Disorders Consortium (UCDC). Dr. Ah Mew has authored multiple publications and book chapters on hyperammonemia and urea cycle disorders and has lectured internationally on these topics. Dr. Ah Mew is also Chair of the DC Committee on Metabolic Disorders, and advisory board to the DC Department of Health regarding matters pertaining to newborn screening in Washington, DC.